Biogen’s muscle disease treatment Spinraza has been deemed too expensive for use on Britain’s state-run health service, even after a price discount offered by the U.S. drugmaker.
(Reuters Health) – The vapor from e-cigarettes may boost the production of inflammatory chemicals in the lungs, while disabling key cellular defenders against infection, a new study suggests.
A dying teenager’s parents begged for her to be sent to the Mayo Clinic. The family says the world-renowned hospital saved her life, then tried to “medically kidnap” her.
Alyssa Gilderhus accuses the Mayo Clinic of trying to “medically kidnap” her. Watch her escape.
In a groundbreaking case against agricultural giant Monsanto, a jury has awarded $250 million in punitive damages and nearly $40 million in compensatory damages to a former school groundskeeper who said he got terminal cancer from the weedkiller Roundup.
Four new cases of Ebola virus have been confirmed in eastern Democratic Republic of Congo, the health ministry said, as authorities prepare to deploy an experimental treatment.
A unit of India’s Hetero Drugs is recalling some batches of the blood pressure and heart medicine valsartan in the United States, a notice on the U.S. regulator’s website said, amid a wider probe into cancer risks associated with the drug.
The US Food and Drug Administration has given its approval for marketing of a mobile medical app to prevent pregnancy, along with a vaginal ring that protects against pregnancy for one year.
A California jury on Friday found Monsanto liable in a lawsuit filed by a man who alleged the company’s glyphosate-based weed-killers, including Roundup, caused his cancer and ordered the company to pay $289 million in damages.
U.S. health regulators on Friday approved Amicus Therapeutics’ Galafold, the first oral therapy to treat Fabry disease, a rare, sometimes fatal condition in which accumulation of fat damages several organs.